Walleye Capital’s Ultralife ULBI Stock Holding History

Walleye Capital’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$214K	Sell	32,880 -5,025	-13%	-$31.2K	﹤0.01%	3306
2025 Q4	$217K	Sell	37,905 -25,802	-41%	-$159K	﹤0.01%	3503
2025 Q3	$434K	Buy	63,707 +32,605	+105%	+$247K	﹤0.01%	2733
2025 Q2	$279K	Buy	31,102 +17,414	+127%	+$103K	﹤0.01%	3100
2025 Q1	$73.6K	Sell	13,688 -3,761	-22%	-$25.6K	﹤0.01%	3728
2024 Q4	$130K	Sell	17,449 -8,017	-31%	-$65.9K	﹤0.01%	4007
2024 Q3	$230K	Sell	25,466 -29,486	-54%	-$304K	﹤0.01%	3897
2024 Q2	$584K	Buy	+54,952	New	+$585K	﹤0.01%	3384

Other funds holding ULBI

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

THC

Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Walleye Capital's ULBI Position: Q1 2026 in Review

Walleye Capital reduced its Ultralife (ULBI) stake by 13% in Q1 2026, selling an estimated $31.2K and leaving 32,880 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #3306.

Walleye Capital first reported a position in ULBI in Q2 2024 and has held it in 8 quarters since. The position peaked at $584K in Q2 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

Walleye Capital held 32,880 shares of Ultralife worth $214K as of Q1 2026.
Walleye Capital sold 5,025 Ultralife shares in Q1 2026, an estimated $31.2K.
Ultralife made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3306 holding.
Walleye Capital first reported a position in Ultralife in Q2 2024 and has held it in 8 quarters since.
Walleye Capital's Ultralife position peaked at $584K in Q2 2024.
50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.